Results
Authors included 17 randomized controlled trials comprising 1,264 patients from 697 citations retrieved from their initial literature search. Mean age of included patients was 66.8 years, and 65% of patients were men. Noninvasive ventilation decreased mortality, decreased need for intubation, and decreased length of hospital stay (Table) . The number needed to treat for an additional beneficial outcome was 12 (95% confidence interval 9 to 23) for mortality benefit and 5 (95% confidence interval 5 to 6) for intubation.
Duration of noninvasive ventilation was highly variable across included studies. Risk of bias because of selection procedures was low for 8 studies, adequate participant blinding occurred in 3 studies, 4 studies had low risk of bias for complete outcome data, and 8 studies demonstrated low risk of bias for selective reporting. Heterogeneity was low for mortality benefit and need for intubation.
Authors graded quality of evidence according to Grading of Recommendations Assessment, Development and Evaluation as moderate because of uncertainty in regard to risk of bias judgments for several studies. Funnel plots indicated low likelihood of publication bias for the outcome of hospital mortality but some asymmetry suggestive of publication bias in regard to the outcome of need for intubation. 
Commentary
Severe chronic obstructive pulmonary disease occurs with hyperinflation, airway obstruction, and decreased respiratory muscle function, and exacerbation can lead to hypercarbic respiratory failure. [2] [3] [4] [5] Conventional therapy includes controlled oxygenation, bronchodilators, corticosteroids, and antibiotics, followed by intubation if these treatments fail. 2, 3, 5, 6 In conjunction with usual care, noninvasive ventilation is beneficial because of positive-pressure ventilation, improving lung mechanics and respiratory muscle function. 7 This meta-analysis presents compelling evidence that noninvasive ventilation reduces mortality, need for intubation, and hospital length of stay in patients with acute hypercapnic respiratory failure from acute chronic obstructive pulmonary disease exacerbation.
This meta-analysis has several limitations. Applicability of these findings to the emergency department is unclear because this was the setting for one trial. Usual care and noninvasive ventilation duration varied among studies. No publication bias was present in mortality benefit, but some potential for publication bias was present in need for intubation. Evidence quality was moderate because of uncertainty in regard to risk-of-bias judgments for several studies. Heterogeneity for mortality and need for intubation was low.
Several limitations for noninvasive positive-pressure ventilation use exist, and it should not be used indiscriminately. Patients with severe altered mental status, severe hypotension, or inadequate secretion control may not tolerate noninvasive ventilation. This metaanalysis demonstrates 11% risk of treatment intolerance with noninvasive ventilation. It carries various risks, including mucus plugging, aspiration, and decreased secretion clearance. 8, 9 This meta-analysis is specific to acute hypercapnic respiratory failure in acute chronic obstructive pulmonary disease, although other data suggest benefit in acute hypercapnic respiratory failure from other causes. 10 Disease severity, defined by degree of acidosis and setting, did not affect outcomes in the meta-analysis. It is possible patients had similar response to noninvasive ventilation despite greater illness severity because of greater availability of health care resources in these settings. Nevertheless, these findings support a trial of noninvasive ventilation even in patients with pH less than 7.30 before proceeding to definitive airway. 
